Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tulisokibart in Active Pulmonary Sarcoidosis
NCT07867938Phase 2Not yet recruiting
- Sponsor
- Merck & Co.
- Start
- Nov 2026
- Primary completion
- Oct 2029
01
Overview
A Phase 2 trial of tulisokibart in pulmonary sarcoidosis, sponsored by Merck & Co.. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
tulisokibart
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT07867938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07867938.